# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Marchex, Inc. (NASDAQ:MCHX), which harnesses the power of AI and conversational intelligence to drive revenue acceleration and ...
Marchex (NASDAQ:MCHX) sees FY2025 sales of $50.000 million vs $50.40 million analyst estimate.
Marchex (NASDAQ:MCHX) sees Q2 sales of $12.500 million vs $11.92 million analyst estimate.